<div class="govuk-grid-row">
  <div class="govuk-grid-column-two-thirds">
    <div class="gem-c-title govuk-!-margin-top-8 govuk-!-margin-bottom-8">
    <span class="govuk-caption-xl gem-c-title__context">
      Guidance
    </span>
  <h1 class="gem-c-title__text gem-c-title__text--long">
    Registering new packaging information for medicines from 1 January 2021
  </h1>
</div>
  </div>
  
  <div class="govuk-grid-column-two-thirds">
    
  <p class="gem-c-lead-paragraph">How and when to register updated packaging and information leaflets when new national marketing authorisations have been issued</p>

  </div>
</div>

<div class="govuk-grid-row">
  <div class="metadata-logo-wrapper">
    <div class="govuk-grid-column-two-thirds metadata-column">
        <div class="app-c-publisher-metadata" lang="en">
    <div class="app-c-published-dates " lang="en">
    Published 1 September 2020
</div>

      <div class="app-c-publisher-metadata__other">
        <dl data-module="track-click">
            <dt class="app-c-publisher-metadata__term">
              From:
            </dt>
            <dd class="app-c-publisher-metadata__definition" data-module="gem-toggle">
                <span class="app-c-publisher-metadata__definition-sentence">
                  <a class="govuk-link" href="/government/organisations/medicines-and-healthcare-products-regulatory-agency">Medicines and Healthcare products Regulatory Agency</a>
                </span>
            </dd>
        </dl>
      </div>
  </div>

    </div>
    <div class="govuk-grid-column-one-third">
    </div>
  </div>
</div>



  <section class="app-c-header-notice" aria-label="notice" role="region">
    <div class="app-c-header-notice__header">
      <h2 class="app-c-header-notice__title">New rules for January 2021</h2>
    </div>

    <div class="app-c-header-notice__content">
          <p class="app-c-header-notice__text govuk-body">The UK has left the EU, and the transition period after Brexit comes to an end this year.</p>
          <p class="app-c-header-notice__text govuk-body">This page tells you what you'll need to do from 1 January 2021. It will be updated if anything changes.</p>
        <div class="app-c-header-notice__links">
            <p class="govuk-body app-c-header-notice__link-intro">
              For current information, read: 
              <a data-module="track-click" data-track-category="no_deal_notice" data-track-action="/guidance/medicines-packaging-labelling-and-patient-information-leaflets" data-track-label="Medicines Packaging Labelling and Patient Information Leaflets" class="app-c-header-notice__link" href="/guidance/medicines-packaging-labelling-and-patient-information-leaflets">Medicines Packaging Labelling and Patient Information Leaflets</a>
            </p>
        </div>

        <p class="app-c-header-notice__text govuk-body">You can also read about <a data-module="track-click" data-track-category="no_deal_notice" data-track-action="/transition" data-track-label="the transition period" class="govuk-link" href="/transition">the transition period</a>.</p>
    </div>
  </section>


<div class="govuk-grid-row">
  <div class="govuk-grid-column-two-thirds">
    

      <div id="contents" class="app-c-contents-list-with-body" data-module="sticky-element-container">
      <div class="responsive-bottom-margin">
          <nav class="gem-c-contents-list  gem-c-contents-list--no-underline " role="navigation" data-module="track-click">
      <h2 class="gem-c-contents-list__title">Contents</h2>

    <ol class="gem-c-contents-list__list">
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--dashed">
          <a class="gem-c-contents-list__link govuk-link " data-track-category="contentsClicked" data-track-action="content_item 1" data-track-label="#actions-to-take-once-you-have-been-issued-an-ma" data-track-options="{"dimension29":"Actions to take once you have been issued an MA\n"}" href="#actions-to-take-once-you-have-been-issued-an-ma">Actions to take once you have been issued an MA
</a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--dashed">
          <a class="gem-c-contents-list__link govuk-link " data-track-category="contentsClicked" data-track-action="content_item 2" data-track-label="#multi-language-packs" data-track-options="{"dimension29":"Multi-language packs"}" href="#multi-language-packs">Multi-language packs</a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--dashed">
          <a class="gem-c-contents-list__link govuk-link " data-track-category="contentsClicked" data-track-action="content_item 3" data-track-label="#national-mas-granted-after-a-mutual-recognition-or-decentralised-procedure" data-track-options="{"dimension29":"National MAs granted after a mutual recognition or decentralised procedure"}" href="#national-mas-granted-after-a-mutual-recognition-or-decentralised-procedure">National MAs granted after a mutual recognition or decentralised procedure</a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--dashed">
          <a class="gem-c-contents-list__link govuk-link " data-track-category="contentsClicked" data-track-action="content_item 4" data-track-label="#submission-and-best-practice" data-track-options="{"dimension29":"Submission and best practice"}" href="#submission-and-best-practice">Submission and best practice</a>

        </li>
    </ol>
</nav>
      </div>
    
      
<div class="gem-c-govspeak govuk-govspeak direction-ltr" data-module="govspeak">
      <div class="govspeak">
<p>Once you have been issued with your new Marketing Authorisation (<abbr title="Marketing Authorisation">MA</abbr>) to convert a previously EU-wide to an <abbr title="Marketing Authorisation">MA</abbr> for Great Britain (GB), you will have no later than 24 months after the end of the transition period to establish and register a GB presence for your <abbr title="Marketing Authorisation">MA</abbr>. This will include submitting amended artwork for approval to accommodate the following new administrative information:</p>

<ul>
  <li>name and address of Marketing Authorisation Holder (MAH) or representative</li>
  <li>GB <abbr title="Marketing Authorisation">MA</abbr> number</li>
  <li>name and address of product manufacturer for batch release</li>
</ul>

<h2 id="actions-to-take-once-you-have-been-issued-an-ma">Actions to take once you have been issued an <abbr title="Marketing Authorisation">MA</abbr>
</h2>

<p>You will have a further 12 months (36 months in total from 1 January 2021) to ensure all stock released to market is in compliant packaging. This additional time allows for assessment of your submission(s) and time for implementation in the production schedule.</p>

<p>You may need to amend the labelling and/or the patient information leaflet (<abbr title="Patient Information Leaflet">PIL</abbr>) to take account of new information as a result of a variation application submitted between the grant of the new <abbr title="Marketing Authorisation">MA</abbr> and 24 months from 1 January 2021. In such cases, the changed artwork which accompanies that variation application should include the new administrative information at that earlier time.</p>

<p>If you are making changes to the labelling and/or the <abbr title="Patient Information Leaflet">PIL</abbr> as a consequence of a variation application, you should submit the full colour mock-ups as part of the variation submission. These will be assessed and approved as part of the variation procedure. Normal fee arrangements apply.</p>

<p>If you are only changing the name and address of the marketing authorisation and/or the manufacturer for batch release (stated in the <abbr title="Patient Information Leaflet">PIL</abbr>) you may do this as part of a Better Regulation of Medicines Initiative (<abbr title="Better Regulation of Medicines Initiative">BROMI</abbr>) notification. Normal fee arrangements apply.</p>

<p>If you are making any other changes to the statutory information or the pack design (which are not consequential to a change to the Summary of Product Characteristics (<abbr title="Summary of Product Characteristics">SmPC</abbr>)), you will need to submit the artwork for full assessment to the Product Information Quality Unit under change code P2. Normal fee arrangements apply.</p>

<p>Packs containing the Falsified Medicines Directive (<abbr title="Falsified Medicines Directive">FMD</abbr>) safety features would still be accepted in the UK, provided that they are in line with other UK packaging requirements.</p>

<h2 id="multi-language-packs">Multi-language packs</h2>

<p>The MHRA will continue to allow multi-country packs, including packs with more than one language on the pack and/or in the <abbr title="Patient Information Leaflet">PIL</abbr>, provided that the entirety of the information is compliant with the UK requirements.</p>

<h2 id="national-mas-granted-after-a-mutual-recognition-or-decentralised-procedure">National MAs granted after a mutual recognition or decentralised procedure</h2>

<p>MAs previously the subject of a mutual recognition or decentralised submission will be considered as purely national licences. Changes to packaging components which previously may have been suitable for submission via an MR 61(3) submission will now be considered under the national rules.</p>

<p>In many cases these changes will be suitable for self-certification under the <abbr title="Better Regulation of Medicines Initiative">BROMI</abbr> scheme. Some changes, however, will need to be submitted for full assessment.</p>

<p>See our information on <a href="https://www.gov.uk/guidance/medicines-packaging-labelling-and-patient-information-leaflets" class="govuk-link">submission categories, best practice guidelines and the fees which apply</a>.</p>

<h2 id="submission-and-best-practice">Submission and best practice</h2>

<p>Full details on how to <a href="https://www.gov.uk/guidance/medicines-packaging-labelling-and-patient-information-leaflets" class="govuk-link">submit applications for assessment, national best practice guidance and the fees</a>.</p>

</div>
</div>


      <div class="responsive-bottom-margin">
        <div class="app-c-published-dates " lang="en">
    Published 1 September 2020
</div>

      </div>

      <div data-sticky-element class="app-c-contents-list-with-body__link-wrapper">
        <div class="app-c-contents-list-with-body__link-container">
          <a class="govuk-link app-c-back-to-top dont-print" href="#contents">
    <svg class="app-c-back-to-top__icon" xmlns="http://www.w3.org/2000/svg" width="13" height="17" viewbox="0 0 13 17">
      <path fill="currentColor" d="M6.5 0L0 6.5 1.4 8l4-4v12.7h2V4l4.3 4L13 6.4z"></path>
    </svg>
    Contents
</a>

        </div>
      </div>
  </div>
  </div>
  
<div class="govuk-grid-column-one-third">
  
<div class="gem-c-contextual-sidebar">
    <div class="gem-c-contextual-sidebar__brexit-cta govuk-!-margin-bottom-6" data-module="track-click">
  <h2 class="gem-c-contextual-sidebar__brexit-heading">Transition period</h2>
  <a href="/transition" class="govuk-link" data-track-category="relatedLinkClicked" data-track-action="1.0 Transition" data-track-label="/transition" data-track-options="{"dimension29":"Find out what it means for you"}">Find out what it means for you</a>
</div>



    
  <div class="gem-c-related-navigation">

      <h2 id="related-nav-related_items-fd807038" class="gem-c-related-navigation__main-heading" data-track-count="sidebarRelatedItemSection">
        Related content
      </h2>




      <nav role="navigation" class="gem-c-related-navigation__nav-section" aria-labelledby="related-nav-collections-fd807038" data-module="gem-toggle">

    <h3 id="related-nav-collections-fd807038" class="gem-c-related-navigation__sub-heading gem-c-related-navigation__sub-heading--sidebar" data-track-count="sidebarRelatedItemSection">Collection</h3>

  <ul class="gem-c-related-navigation__link-list" data-module="track-click">


        <li class="gem-c-related-navigation__link"><a class="gem-c-related-navigation__section-link gem-c-related-navigation__section-link--sidebar" data-track-category="relatedLinkClicked" data-track-action="1.1 Collection" data-track-label="/government/collections/mhra-post-transition-period-information" data-track-options="{"dimension28":"1","dimension29":"MHRA post-transition period information"}" href="/government/collections/mhra-post-transition-period-information">MHRA post-transition period information</a></li>

  </ul>
</nav>

  </div>



</div>

</div>

</div>


  <div class="govuk-grid-row">
    <div class="govuk-grid-column-two-thirds">
        
  <div class="gem-c-contextual-footer">
    
  <div class="gem-c-related-navigation">





      <nav role="navigation" class="gem-c-related-navigation__nav-section" aria-labelledby="related-nav-topics-ffbe9420" data-module="gem-toggle">

    <h2 id="related-nav-topics-ffbe9420" class="gem-c-related-navigation__sub-heading gem-c-related-navigation__sub-heading--footer" data-track-count="footerRelatedItemSection">Explore the topic</h2>

  <ul class="gem-c-related-navigation__link-list" data-module="track-click">


        <li class="gem-c-related-navigation__link"><a class="gem-c-related-navigation__section-link gem-c-related-navigation__section-link--footer" data-track-category="relatedLinkClicked" data-track-action="1.1 Explore the topic" data-track-label="/topic/medicines-medical-devices-blood/manufacturing-wholesaling-importing-exporting-medicines" data-track-options="{"dimension28":"2","dimension29":"Manufacturing, wholesaling, importing and exporting medicines"}" href="/topic/medicines-medical-devices-blood/manufacturing-wholesaling-importing-exporting-medicines">Manufacturing, wholesaling, importing and exporting medicines</a></li>
        <li class="gem-c-related-navigation__link"><a class="gem-c-related-navigation__section-link gem-c-related-navigation__section-link--footer" data-track-category="relatedLinkClicked" data-track-action="1.2 Explore the topic" data-track-label="/topic/medicines-medical-devices-blood/marketing-authorisations-variations-licensing" data-track-options="{"dimension28":"2","dimension29":"Marketing authorisations, variations and licensing guidance"}" href="/topic/medicines-medical-devices-blood/marketing-authorisations-variations-licensing">Marketing authorisations, variations and licensing guidance</a></li>

  </ul>
</nav>

  </div>

  </div>


    </div>
  </div>